Home> Products> egfr mutation positive lung cancer

{ "products": [ { "_id": "69d8e821f75e521c210f0942", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Nilotinib 150mg", "description": "NILOTHERAPY 150 is a prescription medication containing Nilotinib 150 mg, a targeted therapy primarily used in the treatment of certain types of blood cancer. It belongs to a class of drugs known as tyrosine kinase inhibitors (TKIs), which work by blocking specific proteins responsible for cancer cell growth. This medication is widely prescribed for patients diagnosed with Chronic Myeloid Leukemia (CML), especially those who are resistant or intolerant to other treatments.\n\nNILOTHERAPY 150 is designed to provide effective disease control while improving long-term outcomes and quality of life for patients.\n\nWhat is Nilotinib 150 mg?\n\nNilotinib is a second-generation tyrosine kinase inhibitor that specifically targets the BCR-ABL protein, an abnormal protein produced in patients with Chronic Myeloid Leukemia. By inhibiting this protein, NILOTHERAPY 150 helps slow down or stop the uncontrolled growth of cancer cells.\n\nUnlike traditional chemotherapy, Nilotinib is a targeted therapy, meaning it focuses on cancer cells with minimal damage to healthy cells, making it a more precise and often better-tolerated treatment option.\n\nUses of NILOTHERAPY 150\n\nNILOTHERAPY 150 is primarily prescribed for:\n\n1. Chronic Myeloid Leukemia (CML)\nUsed in adults and children diagnosed with Philadelphia chromosome-positive CML.\nEffective in both newly diagnosed patients and those who cannot tolerate other treatments like Imatinib.\n2. Resistant or Intolerant CML Cases\nHelps patients who have not responded adequately to first-line therapies.\nOffers an alternative with improved efficacy in certain resistant mutations.\n3. Long-Term Disease Management\nHelps maintain remission and prevent disease progression to advanced stages such as accelerated or blast phase CML.\nKey Benefits of NILOTHERAPY 150\n1. Targeted Cancer Therapy\n\nNILOTHERAPY 150 directly targets cancer-causing proteins, minimizing damage to healthy cells and reducing many of the harsh side effects associated with chemotherapy.\n\n2. High Effectiveness\n\nClinical studies have shown that Nilotinib can achieve faster and deeper molecular responses compared to older treatments.\n\n3. Improved Survival Rates\n\nPatients using Nilotinib often experience better long-term survival outcomes when taken as prescribed.\n\n4. Oral Administration\n\nUnlike intravenous cancer treatments, NILOTHERAPY 150 is taken orally, making it convenient and easier to incorporate into daily life.\n\n5. Reduced Disease Progression\n\nHelps prevent the progression of CML into more aggressive stages, offering better disease control.\n\n6. Suitable for Resistant Cases\n\nEffective for patients who do not respond well to first-generation TKIs, providing a second chance at disease management.\n\nHow NILOTHERAPY 150 Works\n\nNilotinib works by blocking the activity of the BCR-ABL tyrosine kinase enzyme. This enzyme sends signals that tell cancer cells to grow and divide uncontrollably. By inhibiting this signal, NILOTHERAPY 150:\n\nStops cancer cell multiplication\nInduces cancer cell death\nHelps restore normal blood cell production\nDosage and Administration\nTypically taken twice daily on an empty stomach (at least 2 hours after a meal and 1 hour before the next meal).\nSwallow capsules whole with water.\nAlways follow your doctor’s prescribed dosage and schedule.\n\n⚠️ Do not adjust the dose without medical advice.\n\nPossible Side Effects of NILOTHERAPY 150\n\nLike all medications, NILOTHERAPY 150 may cause side effects. While not everyone experiences them, it’s important to be aware:\n\nCommon Side Effects\nHeadache\nNausea\nFatigue\nSkin rash\nConstipation or diarrhea\nSerious Side Effects\nHeart rhythm problems (QT prolongation)\nLiver function abnormalities\nPancreatitis\nLow blood cell counts\nIncreased blood sugar levels\nWhen to Seek Medical Help\n\nContact your doctor immediately if you experience:\n\nChest pain or irregular heartbeat\nSevere abdominal pain\nUnusual bleeding or bruising\nYellowing of skin or eyes\nPrecautions and Warnings\nInform your doctor if you have a history of heart disease, liver problems, or electrolyte imbalances.\nAvoid grapefruit and grapefruit juice as they may interfere with the drug’s effectiveness.\nRegular blood tests and monitoring are essential during treatment.\nNot recommended during pregnancy or breastfeeding unless advised by a healthcare professional.\nDrug Interactions\n\nNILOTHERAPY 150 may interact with other medications, including:\n\nAntifungal drugs\nAntibiotics\nHeart medications\nCertain antidepressants\n\nAlways inform your healthcare provider about all medicines and supplements you are taking.\n\nStorage Instructions\nStore in a cool, dry place below 25°C\nKeep away from direct sunlight and moisture\nKeep out of reach of children\nConclusion\n\nNILOTHERAPY 150 (Nilotinib 150 mg) is a highly effective, targeted treatment for Chronic Myeloid Leukemia, offering patients a modern alternative to traditional chemotherapy. Its ability to specifically inhibit cancer-causing proteins makes it a powerful tool in controlling disease progression and improving long-term survival.", "price": 3270.0, "discountamount": 981.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2375, "imageuri": "https://productimages.withfloats.com/actual/69d8e8255352fce06529f51e.png", "tileimageuri": "https://productimages.withfloats.com/tile/69d8e8255352fce06529f51e.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-04-10T12:08:01.629Z", "updatedon": "2026-04-14T12:51:27.608Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/nilotinib-150mg/2375", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "NILOTHERAPY 150", "category": "Oncology", "tags": [ "nilotinib 150mg", "nilotinib 150mg capsule", "nilotinib side effects", "nilotinib 150 mg price", "nilotinib 150 mg", "nilotinib 150 mg price", "nilotinib 150mg availability in india", "buy nilotinib 150mg online india prescription", "nilotinib 150mg side effects long term use" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "69cbc41faf13b43636b170d0", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Everolimus Tablets 0.5 mg", "description": "EVERENOLIMUS 0.5 is a prescription medication containing Everolimus 0.5 mg tablets, a potent mTOR (mammalian target of rapamycin) inhibitor used in advanced medical treatments. This medicine works by regulating cell growth, division, and immune system activity, making it effective in both oncology and transplant care.\nEverolimus has become a crucial therapeutic option for patients requiring targeted cancer therapy or immunosuppression after organ transplantation. Its dual functionality—controlling abnormal cell proliferation and preventing organ rejection—makes it a preferred choice among healthcare providers.\nIn India, EVERENOLIMUS 0.5 is increasingly prescribed for specific cancers, post-transplant care, and rare disorders like tuberous sclerosis complex. Its oral tablet form allows convenient administration while maintaining effective systemic action.\n\nUses of EVERENOLIMUS 0.5\n\nEVERENOLIMUS 0.5 is indicated for a range of serious medical conditions:\n1. Organ Transplantation\nHelps prevent rejection of kidney and liver transplants\nMaintains graft survival by suppressing the immune response\n2. Cancer Treatment\nHormone receptor-positive, HER2-negative advanced breast cancer\nAdvanced kidney cancer (renal cell carcinoma)\nNeuroendocrine tumors (pancreas, lungs, gastrointestinal tract)\n3. Tuberous Sclerosis Complex (TSC)\nManages non-cancerous tumors such as subependymal giant cell astrocytoma (SEGA)\nReduces tumor growth in vital organs\n4. Other Rare Conditions\nCertain types of cardiac or renal vascular growth disorders, under specialist supervision\nBenefits of EVERENOLIMUS 0.5\n1. Dual Therapeutic Action\nOffers immunosuppressive benefits for transplant patients\nProvides targeted anti-cancer activity to control abnormal cell growth\n2. Improved Transplant Outcomes\nReduces the risk of graft rejection\nEnsures long-term functionality of transplanted organs\n3. Targeted Cancer Therapy\nFocuses on specific cellular pathways\nMinimizes damage to healthy cells compared to conventional chemotherapy\n4. Slows Disease Progression\nEffective in advanced cancers and benign tumors\nControls disease symptoms and improves patient quality of life\n5. Convenient Oral Formulation\nEasy to take as a tablet without injections\nEnables consistent and controlled drug delivery\n6. Enhances Long-Term Management\nRegular use supports chronic disease control\nReduces hospitalization and complication rates\nDosage of EVERENOLIMUS 0.5\n\nThe exact dosage depends on the patient’s condition, weight, and response to therapy. It must be determined by a healthcare professional.\n\nGeneral Guidelines:\nTypically taken once daily\nSwallow the tablet whole with water\nCan be taken with or without food, but maintain consistency\nMonitoring Requirements:\nRegular blood tests to check kidney and liver function\nMonitoring drug levels ensures effectiveness and safety\nMissed Dose:\nTake the missed dose as soon as possible\nIf it is near the next scheduled dose, skip the missed dose\nDo not double the dose\n\nSide Effects of EVERENOLIMUS 0.5\n\nEVERENOLIMUS 0.5 may cause side effects, which can range from mild to serious.\nCommon Side Effects:\nFatigue and weakness\nNausea or vomiting\nMouth ulcers\nDiarrhea\nLess Common Side Effects:\nEdema (swelling in hands or feet)\nIncreased blood sugar and cholesterol levels\nSkin rash\nSerious Side Effects:\nIncreased risk of infections due to suppressed immunity\nLung inflammation (non-infectious pneumonitis)\nImpaired kidney or liver function\nDelayed wound healing\nWhen to Seek Medical Attention:\nPersistent fever or signs of infection\nShortness of breath or chest pain\nSevere weakness, dizziness, or swelling\nUnusual bleeding or bruising\nPrecautions and Warning\n1. Infection Risk\nSuppressed immunity increases susceptibility to infections\nAvoid exposure to people with contagious diseases\n2. Liver and Kidney Function\nRegular tests are necessary to monitor organ health\n3. Vaccinations\nAvoid live vaccines during treatment\nConsult your doctor before any vaccination\n4. Drug Interactions\nInform your doctor about all medications, including antibiotics, antifungals, and supplements\n5. Pregnancy and Contraception\nNot recommended during pregnancy\nEffective contraception is advised during and after treatment\n6. Surgery and Wound Healing\nInform your doctor before undergoing surgery\nWound healing may be delayed due to Everolimus effects\n7. Sun Protection\nIncreased sensitivity to sunlight\nUse sunscreen and protective clothing\n\nConclusion\n\nEVERENOLIMUS 0.5 (Everolimus Tablets 0.5 mg) is a highly effective oral medication that offers dual benefits for cancer patients and organ transplant recipients. Its targeted mechanism ensures precise therapeutic action while minimizing unnecessary side effects.\nBy preventing organ rejection, controlling tumor growth, and improving long-term outcomes, EVERENOLIMUS 0.5 has become a trusted choice in modern clinical practice. Patients in India seeking reliable, medically supervised care for complex conditions can benefit greatly from this advanced therapy.\nStrict adherence to dosage, regular monitoring, and medical supervision are essential for safe and effective use. Combined with lifestyle and dietary guidance, EVERENOLIMUS 0.5 supports improved quality of life and enhanced clinical outcomes.", "price": 643.0, "discountamount": 193.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2359, "imageuri": "https://productimages.withfloats.com/actual/69cbc421595f848aedb0807c.png", "tileimageuri": "https://productimages.withfloats.com/tile/69cbc421595f848aedb0807c.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-03-31T12:54:55.448Z", "updatedon": "2026-04-14T12:54:29.458Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//everolimus-tablets-0-5-mg/2359", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "EVERENOLIMUS 0.5", "category": "Oncology", "tags": [ "everolimus tablets 0.5 mg uses", "everolimus 0.5 mg dosage and benefits", "everolimus 0.5 mg side effects and precautions", "everolimus 0.5 mg mechanism of action", "everolimus 0.5 mg tablet guide", "everolimus 0.5 mg price in India", "everolimus tablets bulk supplier", "best everolimus tablets 0.5 mg price and uses India", "buy everolimus 0.5 mg tablets online at best price", "everolimus tablets for organ transplant patients India" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6943af86161ad9de85f42b10", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "imatinib 400mg", "description": "IMATIFLOW 400, containing Imatinib IP 400mg, represents a breakthrough in targeted cancer therapy, offering patients a precise weapon against specific malignancies. This oral medication belongs to the class of tyrosine kinase inhibitors, revolutionizing treatment for conditions once deemed challenging to manage. By blocking abnormal proteins that fuel cancer cell growth, IMATIFLOW 400 helps restore normal cellular function and improves quality of life for many users.​\n\nProduct Overview\nIMATIFLOW 400 is a branded formulation of Imatinib mesylate 400mg, produced to high pharmaceutical standards for consistent efficacy and bioavailability. Each tablet delivers the active ingredient in a film-coated form, designed for once-daily administration with food to enhance absorption and minimize gastrointestinal upset. Developed for adult patients, it targets cancers driven by dysregulated tyrosine kinases like BCR-ABL, c-KIT, and PDGFR, making it a cornerstone in modern oncology protocols.​\n\nThe medication's mechanism hinges on competitive inhibition at the ATP-binding site of these kinases, halting downstream signaling pathways that promote uncontrolled proliferation, survival, and metastasis of malignant cells. Unlike traditional chemotherapy, which broadly attacks dividing cells, IMATIFLOW 400 spares most healthy tissues, leading to a more favorable safety profile. Clinical data from pivotal trials underscore its role as first-line therapy, with high response rates observed within months of initiation.​\n\nPrimary Uses\nIMATIFLOW 400 excels in treating chronic myeloid leukemia (CML), particularly in the chronic phase where it induces deep molecular responses in over 80% of patients. It suppresses the Philadelphia chromosome-positive cells hallmark of CML by inhibiting the BCR-ABL fusion protein, dramatically extending progression-free survival. For newly diagnosed patients, standard dosing starts at 400mg daily, often achieving complete cytogenetic remission.​\n\nIn gastrointestinal stromal tumors (GIST), IMATIFLOW 400 targets KIT or PDGFRA mutations, shrinking unresectable tumors and delaying progression in advanced cases. The recommended dose remains 400mg once daily, with potential escalation to 600-800mg for resistant strains, as per oncology guidelines. It also finds application in dermatofibrosarcoma protuberans (DFSP), aggressive systemic mastocytosis, and certain myelodysplastic syndromes, broadening its utility in precision medicine.​\n\nHealthcare providers monitor response via PCR for BCR-ABL transcripts in CML or imaging for GIST, adjusting therapy based on milestones like major molecular response. Patients with Ph+ acute lymphoblastic leukemia (ALL) may receive it adjunctively, enhancing outcomes when combined with chemotherapy. Overall, IMATIFLOW 400 transforms these diseases from fatal to chronically manageable.​\n\nKey Benefits\nOne standout benefit of IMATIFLOW 400 is its oral convenience, eliminating the need for frequent hospital visits associated with infusions. Response rates exceed 90% in early CML, with many patients achieving treatment-free remission after sustained deep responses, a paradigm shift from interferon-era therapies.​\n\nTumor control in GIST prevents life-threatening complications like bowel obstruction, improving survival from months to years. Its specificity reduces severe toxicities, allowing patients to maintain daily activities, work, and social engagements with minimal disruption. Long-term studies report 10-year survival rates above 80% in CML, underscoring durable efficacy.​\n\nAdditional advantages include cost-effectiveness over biologics and compatibility with supportive care like hydroxyurea for cytoreduction. Fluid retention, while common, responds well to diuretics, preserving cardiac function. For Indian patients, accessible pricing via brands like IMATIFLOW 400 supports equitable care in resource-limited settings.​\n\nPotential Side Effects\nWhile generally well-tolerated, IMATIFLOW 400 can cause edema (swelling in legs or face) in up to 70% of users, managed by dose reduction or supportive measures. Gastrointestinal issues like nausea, vomiting, and diarrhea affect 40-50%, often resolving with antiemetics and dietary adjustments.​\n\nMusculoskeletal pain, cramps, and fatigue occur frequently, alongside rash and abdominal discomfort. Hematologic effects include neutropenia or thrombocytopenia, necessitating regular blood counts. Rare but serious risks involve liver enzyme elevation, heart failure, or hemorrhage; prompt reporting of symptoms like shortness of breath or yellowing skin is crucial.​\n\nAvoid grapefruit juice, as it elevates drug levels, and inform doctors of concurrent medications like CYP3A4 inhibitors. Pregnancy category D status advises contraception, with monitoring for growth retardation in exposed fetuses. Dizziness may impair driving, so caution is essential during initial weeks.​\n\nDosage and Administration Guidelines\nSwallow IMATIFLOW 400 whole with a meal and full glass of water to optimize pharmacokinetics and reduce esophageal irritation. The standard adult dose for CML chronic phase is 400mg daily; for accelerated phase or blast crisis, 600mg. GIST dosing mirrors 400mg, titrated based on tolerance and response.​\n\nRenal or hepatic impairment requires dose adjustments—reduce to 300-400mg in moderate cases. Do not crush or chew tablets. Missed doses should be taken promptly unless near the next, avoiding doubles. Long-term use demands quarterly monitoring of CBC, liver function, and ECG.​\n\nPrecautions and Interactions\nPatients with a cardiac history need baseline echocardiograms, as QT prolongation or effusion risks exist. Drug interactions abound: St. John's wort induces metabolism, reducing efficacy; ketoconazole boosts levels. Vaccines, especially live ones, are contraindicated during therapy.​\n\nRegular dermatologic checks mitigate skin cancer risk from prolonged use. Hydration combats fluid retention, and low-salt diets aid management. Steris Healthcare emphasizes patient education via counseling on adherence for optimal outcomes.​\n\nConclusion\nIMATIFLOW 400 (Imatinib IP 400mg) stands as a testament to targeted therapy's power, offering robust control over CML, GIST, and related cancers with a balance of efficacy and manageability. Its benefits in prolonging life and enhancing daily functioning far outweigh transient side effects for most when monitored diligently. Consult oncologists for personalized plans, ensuring this innovative treatment maximizes hope and health in the fight against cancer.", "price": 1827.0, "discountamount": 540.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2249, "imageuri": "https://productimages.withfloats.com/actual/6943b026ca1b0dcfc6c37820.png", "tileimageuri": "https://productimages.withfloats.com/tile/6943b026ca1b0dcfc6c37820.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-12-18T07:38:46.766Z", "updatedon": "2026-04-15T10:27:12.329Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//imatinib-400mg/2249", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "IMATIFLOW 400", "category": "NEPHROLOGYRANGE", "tags": [ "Imatinib IP 400mg", "offering robust control over CML.", "related cancers with a balance of efficacy and manageability.", "innovative treatment maximizes hope and health in the fight against cancer.", "cancer therapy.", "fuel cancer cell growth.", "chemotherapy.", "imatinib 400mg.", "imatinib 400mg tablet.", "tab. imatinib 400mg.", "imatinib 400mg price.", "imatinib 400mg tab", "imatinib 400mg side effects.", "imatinib 400 mg tablet", "imatinib 400 mg medicine", "imatinib tablets 400 mg uses", "imatinib 400 mg dosage", "imatinib 400 mg price in india", "imatinib 400 mg brand name" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6662e95edb100e1fdc2dd5d6", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Imatinib IP 400mg", "description": "IMATIFLOW 400 \nImatinib IP 400mg\n Cancer treatment has advanced significantly over the years, and targeted therapies have transformed outcomes for many patients. One such breakthrough medicine is Imatinib IP 400mg, marketed as IMATIFLOW 400. This medication is widely used in the treatment of certain types of cancers and blood disorders by targeting the underlying disease process at the molecular level.\n\nIMATIFLOW 400 is a trusted formulation of Imatinib that offers effective disease control while improving quality of life when used as prescribed under medical supervision.\n\nWhat Is Imatinib IP 400mg?\n\nImatinib IP 400mg belongs to a class of medicines known as tyrosine kinase inhibitors (TKIs). Unlike traditional chemotherapy that attacks rapidly dividing cells, Imatinib works by specifically blocking abnormal proteins responsible for cancer cell growth.\n\nIMATIFLOW 400 is primarily prescribed for:\n\nChronic Myeloid Leukemia (CML)\n\nGastrointestinal Stromal Tumors (GIST)\n\nCertain rare blood and bone marrow disorders\n\nBy acting at the root cause of disease, Imatinib IP 400mg has become a cornerstone of modern targeted cancer therapy.\n\nHow IMATIFLOW 400 Works\n\nIMATIFLOW 400 works by inhibiting abnormal tyrosine kinase enzymes that signal cancer cells to grow and multiply uncontrollably.\n\nMechanism of Action:\n\nCancer cells produce abnormal proteins due to genetic mutations\n\nThese proteins send continuous growth signals\n\nImatinib blocks these signals\n\nCancer cell growth slows down or stops\n\nDiseased cells gradually die while healthy cells are largely spared\n\nThis targeted approach makes IMATIFLOW 400 more precise and often better tolerated compared to conventional chemotherapy.\n\nUses of Imatinib IP 400mg (IMATIFLOW 400)\n1. Chronic Myeloid Leukemia (CML)\n\nIMATIFLOW 400 is widely used as a first-line treatment for patients with Philadelphia chromosome-positive CML. It helps control disease progression and allows many patients to live longer, more stable lives.\n\n2. Gastrointestinal Stromal Tumors (GIST)\n\nIn patients with inoperable or metastatic GIST, Imatinib IP 400mg helps shrink tumors and prevent further growth.\n\n3. Acute Lymphoblastic Leukemia (ALL)\n\nIn certain cases of Philadelphia chromosome-positive ALL, IMATIFLOW 400 is used as part of combination therapy.\n\n4. Other Rare Conditions\n\nIMATIFLOW 400 may also be prescribed for:\n\nMyelodysplastic syndromes\n\nHypereosinophilic syndrome\n\nCertain dermatological and hematological disorders\n\nKey Benefits of IMATIFLOW 400\nTargeted Cancer Therapy\n\nIMATIFLOW 400 targets cancer cells at a molecular level, reducing unnecessary damage to healthy cells.\n\nImproved Survival Rates\n\nLong-term studies show that Imatinib significantly improves survival and disease control in CML and GIST patients.\n\nOral Administration\n\nUnlike injectable chemotherapy, IMATIFLOW 400 is taken orally, making treatment more convenient.\n\nBetter Quality of Life\n\nPatients often experience fewer severe side effects compared to traditional cancer therapies.\n\nLong-Term Disease Management\n\nMany patients remain on Imatinib therapy for years with stable disease control.\n\nAdvantages of IMATIFLOW 400 Over Conventional Chemotherapy\n\nSpecific action on cancer-causing proteins\n\nLower toxicity profile\n\nReduced hospital visits\n\nImproved patient compliance\n\nSuitable for long-term treatment\n\nThese advantages make IMATIFLOW 400 a preferred choice in targeted oncology care.\n\nDosage and Administration\n\nThe usual dose of Imatinib IP 400mg is one tablet once daily\n\nShould be taken with food and a full glass of water\n\nDosage may vary depending on disease type, stage, and patient response\n\nAlways follow the oncologist’s instructions strictly\n\nDo not stop or adjust the dose without medical advice, as this may affect treatment outcomes.\n\nSide Effects of Imatinib IP 400mg\n\nLike all medicines, IMATIFLOW 400 may cause side effects, although not everyone experiences them.\n\nCommon Side Effects\n\nNausea and vomiting\n\nDiarrhea\n\nMuscle cramps\n\nFatigue\n\nHeadache\n\nSwelling around eyes or ankles\n\nMild skin rash\n\nThese side effects are usually manageable and improve as the body adjusts to the medicine.\n\nSerious Side Effects\n\nAlthough uncommon, some patients may experience serious side effects, including:\n\nSevere fluid retention\n\nLiver function abnormalities\n\nLow blood cell counts\n\nSevere skin reactions\n\nHeart-related complications (rare)\n\nImmediate medical attention is required if severe symptoms occur.\n\nPrecautions and Warnings\n\nRegular blood tests are required during treatment\n\nLiver function monitoring is important\n\nInform the doctor about all other medicines being taken\n\nUse with caution in patients with heart or liver disease\n\nNot recommended during pregnancy unless clearly advised\n\nBreastfeeding should be avoided during treatment\n\nDrug Interactions\n\nIMATIFLOW 400 may interact with:\n\nCertain antibiotics\n\nAntifungal medicines\n\nBlood thinners\n\nHerbal supplements like St. John’s Wort\n\nAlways inform your doctor about any medication or supplement you are using.\n\nWho Should Take IMATIFLOW 400?\n\nPatients diagnosed with CML\n\nPatients with GIST\n\nIndividuals prescribed targeted therapy by an oncologist\n\nPatients requiring long-term cancer management\n\nStorage Instructions\n\nStore at room temperature\n\nKeep away from moisture and heat\n\nKeep out of reach of children\n\nDo not use after the expiry date\n\nFrequently Asked Questions\nIs IMATIFLOW 400 chemotherapy?\n\nNo, it is a targeted therapy, not traditional chemotherapy.\n\nHow long should Imatinib IP 400mg be taken?\n\nTreatment duration depends on disease response and medical advice. Some patients take it long-term.\n\nCan IMATIFLOW 400 cure cancer?\n\nIt helps control and manage cancer effectively, and in many cases keeps the disease in remission.\n\nIs IMATIFLOW 400 safe for long-term use?\n\nYes, when monitored regularly under medical supervision.\n\nConclusion\n\nIMATIFLOW 400 (Imatinib IP 400mg) represents a major advancement in cancer treatment through its targeted mechanism of action. By directly blocking the proteins responsible for cancer growth, it offers effective disease control with improved tolerability. When taken correctly and under medical guidance, IMATIFLOW 400 can significantly enhance survival, stability, and quality of life for patients battling chronic and complex cancers.", "price": 1827.0, "discountamount": 549.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "CML", "Call", "GIST", "Email", "400mg", "types", "cancers", "therapy", "WhatsApp", "IMATIFLOW", "medication", "information", "Imatinib IP", "progression", "sterispharma", "sterisonline", "proliferation", "patient outcomes", "cancer cell growth", "healthcare professional", "chronic myeloid leukemia", "specific tyrosine kinases", "gastrointestinal stromal tumors" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1532, "imageuri": "https://productimages.withfloats.com/actual/667d2405422dd0be2672303b.png", "tileimageuri": "https://productimages.withfloats.com/tile/667d2405422dd0be2672303b.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-07T11:05:02.332Z", "updatedon": "2026-03-16T11:55:37.907Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//imatinib-ip-400mg/1532", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "IMATIFLOW 400 ", "category": "Oncology", "tags": [ "imatinib 400 mg uses", "side effects of imatinib 400 mg", "imatinib 400 mg uses in hindi", "imatinib 400 mg price in india", "imatinib ip 400mg tablet", "imatinib ip 400 mg uses", "imatinib 400mg tablet ip", "imatinib ip 400mg price in india", "imatinib 400mg dosage guide", "imatinib ip 400mg side effects", "imatinib 400mg tablet composition", "imatinib ip 400mg for leukemia", "imatinib 400mg for cml treatment", "imatinib ip 400mg medicine", "imatinib 400mg tablet how to use", "imatinib ip 400mg benefits", "imatinib 400mg oral chemotherapy tablet", "imatinib ip 400mg indications", "imatinib 400mg tablet working mechanism", "buy imatinib ip 400mg tablet", "imatinib ip 400mg manufacturer india", "imatinib 400mg tablet supplier", "imatinib ip 400mg pharmaceutical company", "what is imatinib ip 400mg", "imatinib 400mg tablet for cancer", "imatinib ip 400mg mechanism of action", "imatinib 400mg tablet side effects in patients", "imatinib ip 400mg treatment duration" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "6662e74687f0960e14a2d95a", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Gefitinib 250mg", "description": "\n\nGEFISTERIS 250 is a premium pharmaceutical formulation containing Gefitinib 250mg, a breakthrough targeted therapy medication manufactured by Steris Healthcare. This innovative oral medication represents a significant advancement in the treatment of non-small cell lung cancer (NSCLC), offering patients a precise, scientifically-designed approach to combating one of the world's most challenging malignancies. GEFISTERIS 250 is specifically engineered to target the underlying molecular mechanisms that drive certain types of lung cancer, providing hope and extended survival for patients who carry specific genetic mutations.\nAs a tyrosine kinase inhibitor, GEFISTERIS 250 works at the cellular level to interrupt the signals that tell cancer cells to grow and divide. This targeted approach differs fundamentally from traditional chemotherapy, which affects both healthy and cancerous cells. By focusing specifically on cancer cells with epidermal growth factor receptor (EGFR) mutations, GEFISTERIS 250 offers a more refined treatment strategy with potentially fewer systemic side effects and improved quality of life during treatment.\nUnderstanding Gefitinib 250mg: The Science Behind GEFISTERIS 250\nGefitinib 250mg, the active pharmaceutical ingredient in GEFISTERIS 250, belongs to a revolutionary class of medications known as epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs). The development of this medication marked a paradigm shift in oncology, moving from one-size-fits-all chemotherapy approaches to personalized, mutation-specific treatments.\nThe EGFR protein is found on the surface of cells and plays a crucial role in cell growth and division. In normal cells, EGFR activation is carefully regulated. However, in certain lung cancers, mutations in the EGFR gene cause the receptor to remain constantly active, sending continuous signals for the cell to grow, divide, and survive—leading to uncontrolled cancer growth. GEFISTERIS 250 works by blocking the tyrosine kinase activity of the mutated EGFR protein, effectively turning off the growth signal and causing cancer cells to stop proliferating and eventually die.\nThis precision targeting is what makes GEFISTERIS 250 particularly effective for patients whose tumors harbor activating EGFR mutations, particularly the common exon 19 deletions or exon 21 L858R substitution mutations. Before initiating treatment with GEFISTERIS 250, patients undergo molecular testing to confirm the presence of these mutations, ensuring that the therapy is appropriately matched to their specific cancer biology.\nPrimary Uses and Indications of GEFISTERIS 250\nGEFISTERIS 250 is primarily indicated for the treatment of adult patients with metastatic non-small cell lung cancer whose tumors have specific EGFR mutations. The medication is approved for both first-line treatment in newly diagnosed patients and for those whose disease has progressed after platinum-based chemotherapy.\nFirst-Line Treatment: When EGFR mutations are detected in treatment-naïve patients, GEFISTERIS 250 offers an excellent first-line option, often providing superior progression-free survival compared to traditional chemotherapy regimens. Patients starting with targeted therapy typically experience better tolerability and quality of life during initial treatment phases.\nSecond-Line and Beyond: For patients whose cancer has progressed after chemotherapy, GEFISTERIS 250 provides an effective alternative treatment option, particularly when EGFR mutation testing was not performed initially or when the mutation status was unknown at the time of first treatment.\nThe medication is taken orally as a once-daily tablet, offering significant convenience compared to intravenous chemotherapy that requires hospital visits and lengthy infusion times. This oral administration allows patients to maintain greater independence and normalcy in their daily lives while receiving effective cancer treatment.\nKey Benefits of GEFISTERIS 250\n1. Targeted Cancer Fighting Action\nThe primary benefit of GEFISTERIS 250 lies in its precision targeting mechanism. Unlike conventional chemotherapy that attacks all rapidly dividing cells in the body, GEFISTERIS 250 specifically targets cancer cells bearing EGFR mutations. This selective action means that healthy cells are largely spared, resulting in a more favorable side effect profile and better preservation of normal bodily functions during treatment.\n2. Superior Efficacy in EGFR-Mutant NSCLC\nClinical trials have consistently demonstrated that GEFISTERIS 250 and other EGFR-TKIs provide superior progression-free survival compared to chemotherapy in patients with EGFR-mutant NSCLC. Response rates typically range from 60-80% in appropriate patient populations, with many patients experiencing significant tumor shrinkage and symptomatic improvement within weeks of starting treatment.\n3. Improved Quality of Life\nPatients taking GEFISTERIS 250 often report better quality of life compared to those receiving traditional chemotherapy. The medication's targeted nature results in fewer debilitating side effects such as severe nausea, hair loss, and profound fatigue. Many patients can continue working, traveling, and engaging in normal daily activities while on treatment.\n4. Convenient Oral Administration\nGEFISTERIS 250's once-daily oral dosing eliminates the need for frequent hospital visits for intravenous chemotherapy infusions. Patients take one tablet daily at home, providing tremendous convenience and reducing the burden of treatment. This ease of administration contributes significantly to treatment adherence and patient satisfaction.\n5. Rapid Symptom Relief\nMany patients experience rapid improvement in cancer-related symptoms such as cough, shortness of breath, chest pain, and fatigue within the first few weeks of GEFISTERIS 250 treatment. This quick symptomatic relief can dramatically improve quality of life even before significant tumor shrinkage is visible on imaging studies.\n6. Extended Survival Benefits\nLong-term data demonstrates that appropriate use of EGFR-TKIs like GEFISTERIS 250 contributes to extended overall survival in patients with EGFR-mutant lung cancer. When used as part of a comprehensive treatment strategy, including potential sequential therapies after progression, patients can achieve survival times that were unimaginable before the advent of targeted therapies.\n7. Manageable Side Effect Profile\nWhile GEFISTERIS 250 does cause side effects, they are generally more manageable than those associated with traditional chemotherapy. Most side effects can be effectively controlled with supportive medications, dose modifications, or temporary treatment interruptions, allowing patients to continue benefiting from therapy.\n8. Quality Manufacturing by Steris Healthcare\nGEFISTERIS 250 benefits from Steris Healthcare's commitment to pharmaceutical excellence. Each tablet undergoes rigorous quality testing to ensure consistent potency, purity, and bioavailability. This quality assurance means patients receive reliable, effective medication with every dose.\nSide Effects of GEFISTERIS 250 (Gefitinib 250mg)\nWhile GEFISTERIS 250 offers significant therapeutic benefits, patients should be aware of potential side effects. Understanding these effects enables early recognition and appropriate management.\nCommon Side Effects (Affecting 20% or More of Patients):\nSkin Reactions: The most characteristic side effect of GEFISTERIS 250 is an acne-like rash, typically appearing on the face, chest, and back within the first few weeks of treatment. This rash, while cosmetically concerning for some patients, actually correlates with better treatment response. The rash can be managed with topical antibiotics, moisturizers, and sun protection. In severe cases, temporary dose reduction may be necessary.\nDiarrhea: Approximately 50-60% of patients experience diarrhea of varying severity. Mild diarrhea can often be managed with dietary modifications and over-the-counter anti-diarrheal medications like loperamide. Patients should stay well-hydrated and contact their healthcare provider if diarrhea becomes severe or persistent, as dose adjustments may be needed.\nNail Changes: Some patients develop paronychia (nail bed inflammation) or other nail abnormalities. Proper nail care, avoiding trauma to the nail beds, and wearing protective gloves during housework can help minimize these effects.\nDry Skin: Many patients experience skin dryness and itching. Regular use of fragrance-free moisturizers, gentle cleansers, and avoidance of hot showers can help manage these symptoms.\nMouth Sores: Oral mucositis or stomatitis can develop in some patients. Good oral hygiene, avoiding spicy or acidic foods, and using alcohol-free mouthwashes can provide relief.\nLess Common but Serious Side Effects:\nInterstitial Lung Disease (ILD): While rare (1-2% of patients), ILD is the most serious potential side effect of GEFISTERIS 250. Symptoms include sudden onset or worsening of respiratory symptoms such as difficulty breathing, cough, or fever. This requires immediate medical attention and usually necessitates permanent discontinuation of the medication.\nLiver Function Abnormalities: Elevated liver enzymes can occur, requiring regular monitoring through blood tests. Most cases are asymptomatic and reversible with dose modification or temporary discontinuation.\nEye Problems: Dry eyes, corneal erosion, or other ocular issues may develop. Regular use of lubricating eye drops and ophthalmological evaluation when symptoms occur can prevent serious complications.\nGastrointestinal Perforation: Though rare, serious gastrointestinal complications including perforation can occur, particularly in patients with underlying GI conditions.\nManagement Strategies:\nMost side effects can be effectively managed through:\n\nProactive supportive care and prophylactic measures\nDose modifications (reduction to 250mg every other day in some cases)\nTemporary treatment interruptions allowing recovery\nSymptomatic treatment with appropriate medications\nPatient education about early recognition and reporting of symptoms\n\nPatients should maintain open communication with their healthcare team, reporting any new or worsening symptoms promptly. Regular monitoring through clinical visits and laboratory testing helps identify and address side effects before they become serious.\nDosage and Administration Guidelines\nThe standard dose of GEFISTERIS 250 is one 250mg tablet taken orally once daily, with or without food. The tablet should be swallowed whole with water and should not be crushed or chewed. If a dose is missed and it's been less than 12 hours since the scheduled time, patients should take the missed dose. If more than 12 hours have passed, skip the missed dose and resume the regular schedule—never double up on doses.\nTreatment continues until disease progression or unacceptable toxicity occurs. Some patients remain on GEFISTERIS 250 for months or even years if they continue to benefit without prohibitive side effects. Dose modifications may be necessary based on individual tolerance, typically reducing the frequency to every other day rather than lowering the individual dose.\nPrecautions and Important Considerations\nPatients taking GEFISTERIS 250 should be aware of several important precautions. The medication can cause harm to developing fetuses, so women of childbearing potential must use effective contraception during treatment and for at least two weeks after the last dose. Breastfeeding should be avoided during treatment and for two weeks after completion.\nGEFISTERIS 250 can interact with medications that affect stomach acid, including proton pump inhibitors and H2-receptor antagonists. If antacids are needed, they should be taken several hours apart from GEFISTERIS 250. The medication may also interact with certain other drugs metabolized by the liver, so patients should inform their healthcare provider about all medications, supplements, and herbal products they're taking.\nRegular monitoring is essential during GEFISTERIS 250 treatment, including periodic liver function tests, pulmonary symptom assessment, and clinical evaluation for skin and other toxicities. Patients should avoid prolonged sun exposure and use high-SPF sunscreen, as the medication can increase photosensitivity.\nConclusion\nGEFISTERIS 250 represents a transformative treatment option for patients with EGFR-mutant non-small cell lung cancer, offering targeted, effective therapy with a manageable side effect profile. Manufactured by Steris Healthcare with unwavering commitment to quality and patient outcomes, GEFISTERIS 250 delivers Gefitinib 250mg in a formulation designed for optimal bioavailability and consistent therapeutic effect.\nThe medication's precision targeting of cancer-driving mutations, combined with convenient oral administration and generally tolerable side effects, makes GEFISTERIS 250 an excellent choice for eligible patients. While side effects do occur and require monitoring and management, the potential benefits—including tumor response, symptom improvement, extended progression-free survival, and enhanced quality of life—often significantly outweigh the risks for appropriately selected patients.\nSuccess with GEFISTERIS 250 requires partnership between patients and their healthcare teams. Molecular testing to confirm EGFR mutation status before treatment, adherence to the prescribed regimen, proactive management of side effects, and regular monitoring all contribute to optimal outcomes. For many patients with EGFR-mutant lung cancer, GEFISTERIS 250 offers not just treatment, but genuine hope for extended, quality life.\nAs personalized medicine continues to evolve, medications like GEFISTERIS 250 exemplify the power of matching treatments to individual tumor characteristics. Steris Healthcare's commitment to delivering this advanced therapy with assured quality and accessibility ensures that more patients can benefit from the remarkable advances in targeted cancer treatment that Gefitinib 250mg represents.\n", "price": 2760.0, "discountamount": 828.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "food", "Call", "Uses", "Rash", "Note", "NSCLC", "Email", "nausea", "Dosage", "spread", "WhatsApp", "diarrhea", "Gefitinib", "treatment", "One tablet", "GEFISTERIS", "information", "sterispharma", "consultation", "sterisonline", "Side Effects", "cancer cells", "targeted therapy", "Regular monitoring", "healthcare provider", "small cell lung cancer", "healthcare professional", "specific EGFR mutations", "epidermal growth factor receptor", "potential liver function alterations" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1530, "imageuri": "https://productimages.withfloats.com/actual/667d25ffb56721898510e93e.png", "tileimageuri": "https://productimages.withfloats.com/tile/667d25ffb56721898510e93e.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-07T10:56:06.808Z", "updatedon": "2026-04-15T10:04:00.767Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//gefitinib-250mg/1530", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GEFISTERIS 250", "category": "Oncology", "tags": [ "gefitinib 250 mg uses", "gefitinib 250 mg online purchase", "gefitinib 250 mg tablets price in india", "non-small cell lung cancer (NSCLC).", "triggered by chemotherapy.", "cancer biology.", "Superior Efficacy in EGFR-Mutant NSCLC", "gefitinib 250mg", "gefitinib 250mg tablet", "gefitinib 250mg tab", "gefitinib 250 mg tablet uses in lung cancer", "gefitinib tablets 250 mg dosage and benefits", "gefitinib 250 mg price in india", "gefitinib 250 mg EGFR inhibitor for NSCLC treatment india" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "6662c47c2bed1f08484d6c10", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "TAMOXIFILM 20 ", "description": "TAMOXIFILM 20 \nTamoxifen IP (20mg)\nTamoxifilm 20 contains Tamoxifen IP at a concentration of 20mg per dose. Tamoxifen is a medication commonly used in the treatment of breast cancer. It belongs to a class of drugs known as selective estrogen receptor modulators (SERMs). Tamoxifen works by blocking the effects of estrogen in the breast tissue, thereby slowing down or stopping the growth of cancer cells that require estrogen to grow.\n\nTamoxifilm 20 is typically prescribed for:\n\nBreast Cancer: It is effective in both early-stage and advanced breast cancer cases. It may be used before surgery to reduce tumor size or after surgery to prevent the recurrence of cancer.\n\nPrevention: Tamoxifen is also used for reducing the risk of developing breast cancer in high-risk individuals, especially those with a family history of breast cancer or certain genetic mutations.\n\nHormone Receptor-Positive Breast Cancer: It is particularly beneficial for hormone receptor-positive breast cancers, where the cancer cells have receptors for estrogen or progesterone.\n\nMetastatic Breast Cancer: In cases where breast cancer has spread to other parts of the body, Tamoxifen can help in controlling the spread and managing the symptoms.\n\nUsage and Dosage:\n\nTamoxifilm 20 is usually taken orally, with or without food.\nThe typical dosage for breast cancer treatment is 20mg to 40mg daily, usually for 5 years or as directed by the healthcare provider.\nFor prevention purposes, the dosage may vary depending on individual risk factors and medical history.For further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nOrder Now: \n\nhttps://www.sterisonline.com/product/tamoxifilm-20-133689", "price": 32.0, "discountamount": 9.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "body", "Call", "dose", "20mg", "40mg", "food", "SERMs", "drugs", "Order", "Usage", "class", "Email", "spread", "growth", "surgery", "effects", "5 years", "WhatsApp", "symptoms", "receptors", "tumor size", "recurrence", "medication", "TAMOXIFILM", "information", "other parts", "early-stage", "sterispharma", "progesterone", "sterisonline", "cancer cells", "Tamoxifen IP", "breast tissue", "concentration", "family history", "typical dosage", "medical history", "genetic mutations", "healthcare provider", "prevention purposes", "high-risk individuals", "breast cancer treatment", "individual risk factors", "Metastatic Breast Cancer", "advanced breast cancer cases", "selective estrogen receptor modulators", "hormone receptor-positive breast cancers" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1511, "imageuri": "https://productimages.withfloats.com/actual/667d3e4b000f6c164f0965cb.png", "tileimageuri": "https://productimages.withfloats.com/tile/667d3e4b000f6c164f0965cb.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-07T08:27:40.343Z", "updatedon": "2026-03-17T07:23:45.081Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//tamoxifilm-20-/1511", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "TAMOXIFILM 20 ", "category": "NEPHROLOGYRANGE", "tags": [ "", "tamoxifen 20 mg uses", "tamoxifen 20 mg dosage", "", "tamoxifen 20 mg side effects", "tamoxifen 20 mg brand name", "tamoxifen 20 mg buy online" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "69d8d9f47c7c4d696c414270", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Nilotinib 200mg", "description": "NILOTHERAPY 200 is a targeted anti-cancer medication containing Nilotinib 200 mg, primarily used in the treatment of chronic myeloid leukemia (CML). It belongs to a class of medicines known as tyrosine kinase inhibitors (TKIs), which work by blocking the abnormal proteins responsible for cancer cell growth.\n\nDeveloped to provide more precise and effective cancer treatment, NILOTHERAPY 200 offers improved outcomes compared to traditional therapies. It is commonly prescribed for patients who are newly diagnosed with CML or those who have not responded well to other treatments.\n\nWhat is Nilotinib and How Does It Work?\n\nNilotinib is a second-generation tyrosine kinase inhibitor that specifically targets the BCR-ABL protein, a key driver of leukemia cell growth.\n\nMechanism of Action\nBlocks abnormal signals that promote cancer cell multiplication\nStops the growth and spread of leukemia cells\nHelps restore normal blood cell production\n\nUnlike chemotherapy, which affects both healthy and cancerous cells, Nilotinib works in a targeted manner, reducing damage to normal cells and improving treatment tolerability.\n\nUses of NILOTHERAPY 200\n1. Treatment of Chronic Myeloid Leukemia (CML)\n\nNILOTHERAPY 200 is widely used for:\n\nNewly diagnosed Philadelphia chromosome-positive CML\nChronic phase and accelerated phase CML\nPatients resistant or intolerant to prior therapies\n2. Long-Term Disease Control\n\nIt helps maintain remission and prevents disease progression when taken regularly as prescribed.\n\n3. Alternative to First-Line Therapies\n\nFor patients who do not respond well to other medications, NILOTHERAPY 200 serves as an effective alternative.\n\nKey Benefits of NILOTHERAPY 200\n1. Targeted Cancer Therapy\n\nNILOTHERAPY 200 specifically attacks cancer cells without extensively harming healthy cells, making it more precise than conventional chemotherapy.\n\n2. High Effectiveness in CML Management\n\nClinical studies have shown that Nilotinib provides:\n\nFaster molecular response\nImproved long-term survival rates\nReduced risk of disease progression\n3. Oral Convenience\n\nThe capsule form allows patients to take the medication at home, avoiding frequent hospital visits.\n\n4. Improved Quality of Life\n\nPatients often experience fewer severe side effects compared to traditional treatments, enabling better daily functioning.\n\n5. Suitable for Resistant Cases\n\nEffective in patients who have developed resistance to earlier therapies like imatinib.\n\nDosage and Administration\nTypically taken twice daily, approximately 12 hours apart\nMust be taken on an empty stomach (avoid food 2 hours before and 1 hour after)\nSwallow capsules whole with water\nFollow your doctor’s exact dosage instructions\nImportant Tip\n\nDo not skip doses or stop treatment without medical advice, as this may affect treatment outcomes.\n\nPossible Side Effects of NILOTHERAPY 200\n\nLike all medications, NILOTHERAPY 200 may cause side effects. While many are manageable, some require immediate attention.\n\nCommon Side Effects\nHeadache\nNausea\nFatigue\nConstipation or diarrhea\nMuscle or joint pain\nSerious Side Effects\nHeart rhythm problems (QT prolongation)\nLiver function abnormalities\nPancreatitis\nLow blood cell counts\nSudden weight gain or swelling\nWhen to Seek Medical Help\n\nContact your doctor immediately if you experience:\n\nIrregular heartbeat\nSevere abdominal pain\nYellowing of skin or eyes\nUnusual bleeding or bruising\nPrecautions and Warnings\n\nBefore starting NILOTHERAPY 200, consider the following:\n\nInform your doctor if you have heart disease, liver problems, or electrolyte imbalance\nRegular ECG monitoring may be required\nAvoid grapefruit and grapefruit juice during treatment\nNot recommended during pregnancy unless prescribed\nUse effective contraception during treatment\nDrug Interactions\n\nNilotinib may interact with:\n\nAntifungal medications\nAntibiotics\nHeart rhythm drugs\nAntacids\n\nAlways inform your healthcare provider about all medicines and supplements you are taking.\n\nStorage Instructions\nStore below 30°C in a dry place\nKeep away from moisture and direct sunlight\nKeep out of reach of children\nWhy Choose NILOTHERAPY 200?\n\nNilotherapy 200 stands out due to the following:\n\nAdvanced targeted therapy mechanism\nProven success in treating CML\nConvenient oral dosage\nEffective in resistant and intolerant cases\nTrusted pharmaceutical quality\nConclusion\n\nNILOTHERAPY 200 (Nilotinib 200 mg Capsules) is a powerful and reliable treatment option for patients with chronic myeloid leukemia. Its targeted mechanism, high effectiveness, and convenient oral administration make it a preferred choice among healthcare professionals.", "price": 3570.0, "discountamount": 1071.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2374, "imageuri": "https://productimages.withfloats.com/actual/69d8d9fb0f2d50aed157389c.png", "tileimageuri": "https://productimages.withfloats.com/tile/69d8d9fb0f2d50aed157389c.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-04-10T11:07:32.379Z", "updatedon": "2026-05-26T06:50:48.256Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//nilotinib-200mg/2374", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "NILOTHERAPY 200", "category": "Oncology", "tags": [ "nilotinib 200mg", "nilotinib 200mg price", "tab nilotinib 200mg", "nilotinib 200mg price in india", "nilotinib 200mg in hindi", "nilotinib 200mg tab", "nilotinib 200mg side effects", "nilotinib 200mg brands in india", "nilotinib 200mg uses", "nilotinib 200mg price online", "nilotinib 200mg generic vs branded price comparison0", "is nilotinib 200mg available without prescription India", "nilotinib 200mg lead time suppliers India", "nilotinib 200mg vs imatinib price India", "nilotinib 200mg exporters from India", "nilotinib 200mg global suppliers GMP WHO certified", "nilotinib 200mg hospital procurement price India", "Buy Nilotinib 200mg Capsules Online", "Nilotinib 200mg Anti Cancer Medicine", "Nilotinib 200mg Prescription Medicine", "Nilotinib 200mg Product Image", "Best Leukemia Treatment Medicine Nilotinib", "Nilotinib Capsules for Blood Cancer Treatment", "Nilotinib 200mg Oncology Medicine", "Targeted Cancer Therapy Capsules", "Nilotinib 200mg Chemotherapy Support Medicine" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "68272992e579986392b124bf", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Nintedanib 150mg", "description": "NINTEPRIDE 150 is a prescription medication that contains Nintedanib 150 mg, a targeted therapy used primarily in the treatment of idiopathic pulmonary fibrosis (IPF), systemic sclerosis-associated interstitial lung disease (SSc-ILD), and certain types of non-small cell lung cancer (NSCLC). It works by slowing the progression of fibrotic diseases, helping to maintain better lung function and improving the patient's quality of life.\n\nKey Ingredient\nNintedanib (150 mg)\nNintedanib is a tyrosine kinase inhibitor that blocks several growth factor receptors responsible for promoting fibrosis and tumor growth. It is an orally administered compound used in chronic and progressive lung conditions.\n\nKey Benefits\nHelps slow down the progression of idiopathic pulmonary fibrosis (IPF).\n\nImproves lung function and delays further decline in lung capacity.\n\nUsed as a treatment for systemic sclerosis-associated interstitial lung disease (SSc-ILD).\n\nBeneficial in certain types of advanced non-small cell lung cancer (NSCLC).\n\nTargets multiple pathways involved in fibrosis and tumor progression.\n\nProvides a convenient oral dosage form for chronic conditions.\n\nHow Does It Work?\nNINTEPRIDE 150 (Nintedanib 150 mg) works by inhibiting multiple receptor tyrosine kinases, including those for platelet-derived growth factor (PDGF), fibroblast growth factor (FGF), and vascular endothelial growth factor (VEGF). These growth factors are responsible for the development and progression of fibrosis and abnormal cell proliferation. By blocking these receptors, Nintedanib helps to:\n\nReduce the formation of scar tissue in the lungs.\n\nDecrease inflammation and tissue remodeling.\n\nInhibit tumor angiogenesis in certain cancer types.\n\nPreserve lung structure and function over time.\n\nDirections for Use\nNINTEPRIDE 150 should be taken orally, twice daily (usually one capsule in the morning and one in the evening).\n\nTake the capsule with food and water to reduce the risk of gastrointestinal side effects.\n\nDo not chew or crush the capsule; swallow it whole.\n\nTake the medication at the same times each day for optimal results.\n\nFollow the dosage and schedule prescribed by your healthcare provider.\n\nIf a dose is missed, skip it and continue with the next scheduled dose. Do not take a double dose.\n\nSide Effects\nNINTEPRIDE 150 may cause some common and serious side effects. It is important to report any persistent or severe symptoms to a healthcare professional.\n\nCommon Side Effects:\n\nDiarrhea\n\nNausea\n\nVomiting\n\nLoss of appetite\n\nWeight loss\n\nAbdominal pain\n\nLiver enzyme elevation\n\nSerious Side Effects:\n\nSevere liver problems\n\nBleeding complications\n\nGastrointestinal perforation\n\nHeart-related issues such as increased blood pressure or myocardial infarction\n\nHypersensitivity reactions including rash, itching, or swelling\n\nRegular liver function monitoring and clinical follow-up are essential while on NINTEPRIDE 150 to ensure safe and effective use.", "price": 987.0, "discountamount": 487.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": [ "nintepride 150", "tumor progression", "capsule swallow", "promoting fibrosis", "nintepride 150nintepride 150", "scheduled dose", "chronic conditions", "lung function", "prescription medication", "ensure safe", "clinical followup", "rash itching", "severe symptoms", "missed skip", "healthcare provider", "schedule prescribed", "time directions", "scar tissue", "growth factors", "lung capacity", "tumor growth", "patients quality", "targeted therapy", "nintedanib 150 mg", "side effects", "gastrointestinal side effects", "orally administered compound", "receptors nintedanib helps", "increased blood pressure", "optimal results follow", "lungs decrease inflammation", "abnormal cell proliferation", "tyrosine kinase inhibitor", "fibrotic diseases helping" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2116, "imageuri": "https://productimages.withfloats.com/actual/682729941972da8c8f537bca.png", "tileimageuri": "https://productimages.withfloats.com/tile/682729941972da8c8f537bca.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-05-16T12:03:30.781Z", "updatedon": "2026-04-30T08:13:06.722Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//nintedanib-150mg/2116", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "NINTEPRIDE 150", "category": "NEPHROLOGYRANGE", "tags": [ "Nintedanib 150 mg", "Nintedanib 150 mg price in India", "Nintedanib 150 mg brands in India", "Nintedanib 150 mg side effects", "nintedanib soft gelatin capsules", "nintedanib soft gelatin capsules uses in hindi", "nintedanib soft gelatin capsules 150 mg", "nintedanib soft gelatin capsules 150 mg", "nintedanib soft gelatin capsules 150mg uses", "nintedanib soft gelatin capsules 150mg price", "rx nintedanib soft gelatin capsules", "nintedanib soft gelatin capsules 150 mg price India", "nintedanib 150 mg twice daily dosage schedule", "buy nintedanib 150 mg soft gelatin capsules online", "nintedanib 150 mg capsules price per strip", "Nindanib 150 soft gelatin capsule buy online" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "66d999cc236afd258ed10348", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Nintedanib 100 mg", "description": "NINTEDONE 100 \nNintedanib 100 mg is a cutting-edge oral medication designed to combat progressive lung conditions and certain cancers, offering hope to patients facing debilitating fibrotic diseases. As a small-molecule tyrosine kinase inhibitor, it targets key pathways involved in abnormal cell growth and tissue scarring, making it a vital therapy for idiopathic pulmonary fibrosis (IPF), systemic sclerosis-associated interstitial lung disease (SSc-ILD), and progressive fibrosing interstitial lung diseases (PF-ILD). Manufactured to high standards, this formulation delivers precise dosing in a convenient capsule form, ensuring consistent absorption and efficacy for long-term management.​\n\nUses of Nintedanib 100 mg\nNintedanib 100 mg stands out for its approved indications in slowing the decline of lung function in adults with IPF, a chronic and fatal lung disease characterized by progressive scarring of lung tissue. It is also indicated for SSc-ILD, where it helps manage lung fibrosis associated with systemic sclerosis, and PF-ILD, covering other chronic fibrosing lung conditions with a progressive phenotype. Beyond pulmonary fibrosis, Nintedanib has shown utility in oncology, particularly when combined with docetaxel for second-line treatment of advanced non-small cell lung cancer (NSCLC) of adenocarcinoma tumor histology, inhibiting tumor angiogenesis and growth.​\n\nThis medication addresses the underlying fibrotic processes by restricting fibroblast proliferation and migration, which are central to lung tissue damage. In clinical practice, physicians prescribe Nintedanib 100 mg for patients with confirmed diagnoses via high-resolution CT scans or lung biopsies, often after other treatments fail. Its versatility extends to off-label considerations in other cancers like pancreatic or colorectal, though primary use remains in respiratory fibrosis and lung cancer, providing a targeted approach where traditional therapies fall short.​\n\nKey Benefits of Nintedanib 100 mg\nOne of the primary benefits of Nintedanib 100 mg is its proven ability to reduce the rate of forced vital capacity (FVC) decline, a key measure of lung function, by up to 50% in IPF patients compared to placebo in landmark trials. This translates to slower disease progression, fewer acute exacerbations, and improved quality of life, allowing patients to maintain daily activities longer. The oral administration enhances patient compliance, avoiding the need for infusions or hospital visits.​\n\nSlows Fibrosis Progression: By inhibiting multiple tyrosine kinases, it curbs excessive scar tissue formation in the lungs, preserving respiratory capacity over time.​\n\nAnti-Angiogenic Effects: In cancer settings, it blocks vascular endothelial growth factor receptors (VEGFR), reducing tumor blood supply and metastasis risk.​\n\nBroad-Spectrum Kinase Inhibition: Targets fibroblast growth factor receptors (FGFR), platelet-derived growth factor receptors (PDGFR), and others, addressing multifaceted disease pathways.​\n\nManageable Long-Term Use: Clinical data supports sustained benefits with dose adjustments, minimizing hospitalizations for respiratory failure.​\n\nImproved Survival Metrics: In combination therapies for NSCLC, it extends progression-free survival, offering valuable time for patients.​\n\nThese advantages make Nintedanib 100 mg a cornerstone in modern pulmonology and oncology, backed by phase III trials demonstrating statistically significant outcomes in diverse patient populations.​\n\nSide Effects of Nintedanib 100 mg\nWhile effective, Nintedanib 100 mg can cause gastrointestinal side effects as the most common issue, affecting over 60% of users primarily due to its impact on kinase signaling in the gut. Diarrhea often starts within the first two weeks and is typically manageable with dose reduction or antidiarrheal agents like loperamide. Other frequent effects include nausea, vomiting, and decreased appetite, which may lead to weight loss if not addressed.​\n\nMore serious side effects warrant close monitoring:\n\nLiver Enzyme Elevations: Hepatotoxicity occurs in about 10-15% of patients, necessitating monthly liver function tests, especially in those with pre-existing liver conditions.​\n\nCardiovascular Risks: Potential for arterial thromboembolism or hypertension; baseline cardiac evaluation is recommended.​\n\nBleeding Events: Due to VEGF inhibition, minor bleeding like epistaxis is common, but gastrointestinal hemorrhage requires immediate attention.​\n\nRare but Severe: Interstitial lung disease progression (paradoxical worsening), perforations, or severe infections in immunocompromised patients.​\n\nPatients should report persistent diarrhea, abdominal pain, jaundice, or unusual fatigue promptly. Contraindications include pregnancy (category D), active bleeding, or hypersensitivity, with strong recommendations against use in moderate to severe hepatic impairment.​\n\nDosage and Administration Insights\nTypically initiated at 150 mg twice daily for IPF and ILD, Nintedanib 100 mg allows for flexible dosing—starting lower at 100 mg BID if tolerated poorly, with food to reduce GI upset. For NSCLC, it's 200 mg BID with docetaxel cycles. Regular monitoring every 2-3 months adjusts for tolerance, emphasizing adherence to slow disease modification.​\n\nConclusion\nNintedanib 100 mg represents a breakthrough in managing progressive fibrotic lung diseases and select cancers, delivering targeted inhibition of fibrotic and angiogenic pathways for tangible clinical benefits. Its ability to slow FVC decline, enhance patient quality of life, and integrate into combination regimens underscores its value, despite manageable side effects like diarrhea that respond well to supportive care. For those battling IPF, SSc-ILD, or NSCLC, Nintedanib 100 mg offers a proactive defense against relentless progression, empowering longer, more active lives under specialist guidance.​", "price": 795.0, "discountamount": 296.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "one capsule", "weight loss", "scar tissue", "key players", "Key Benefits", "lung function", "initial stages", "abdominal pain", "fibrous tissue", "key ingredient", "Bleeding Events", "fibrotic tissue", "daily activities", "tyrosine kinases", "fibrotic process", "Nintedanib 100 mg", "multiple pathways", "active ingredient", "sudden worsenings", "crucial medication", "recommended dosage", "Decreased Appetite", "signaling pathways", "multiple receptors", "overall well-being", "disease progression", "acute exacerbations", "healthcare provider", "Common side effects", "elevated liver enzymes", "Gastrointestinal Issues", "other fibrotic diseases", "Liver Enzyme Elevations", "tyrosine kinase inhibitor", "progressive lung conditions", "other fibrotic lung diseases", "idiopathic pulmonary fibrosis", "potent pharmaceutical formulation", "fibroblast growth factor receptor", "platelet-derived growth factor receptor", "vascular endothelial growth factor receptor" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1971, "imageuri": "https://productimages.withfloats.com/actual/66d999d4f2036c2969cdeca8.png", "tileimageuri": "https://productimages.withfloats.com/tile/66d999d4f2036c2969cdeca8.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-09-05T11:45:16.665Z", "updatedon": "2026-03-14T06:46:45.85Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//nintedanib-100-mg/1971", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "NINTEDONE 100 ", "category": "NEPHROLOGYRANGE", "tags": [ "lung conditions and certain cancers", "Nintedanib 100 mg", "pulmonary fibrosis (IPF)", "fibrosis and lung cancer", "nintedanib 100 mg", "nintedanib capsules 100 mg", "nintedanib 100 mg capsules", "nintedanib 100 mg medicine", "nintedanib 100 mg tablet uses", "what is nintedanib 100 mg used for", "how nintedanib 100 mg works", "nintedanib 100 mg uses and benefits", "nintedanib 100 mg for lung disease", "nintedanib 100 mg for pulmonary fibrosis", "nintedanib 100 mg for idiopathic pulmonary fibrosis", "nintedanib 100 mg for interstitial lung disease", "nintedanib capsules for chronic lung disease", "nintedanib 100 mg price in india", "nintedanib 100 mg capsules price", "buy nintedanib 100 mg online", "nintedanib 100 mg supplier india", "nintedanib 100 mg manufacturer", "when should nintedanib 100 mg be taken", "who should take nintedanib 100 mg", "can nintedanib slow lung fibrosis", "how long to take nintedanib 100 mg", "does nintedanib cure pulmonary fibrosis" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }